Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

University Day at Carolina
Each year on Oct. 12, Carolina celebrates University Day, which marks the laying of the cornerstone of Old East — the campus’ first building and...
Wed Oct 8, 2025

Franklin Street is a revolving door for closing and opening restaurants
The Purple Bowl is an acai restaurant that has been on Franklin Street for about eight years. McClaren Hopper, the restaurant’s general manager, said community...
Tue Oct 7, 2025

Professor Dwayne Dixon reinstated by UNC following 'thorough threat assessment'
UNC Asian and Middle Eastern Studies professor Dwayne Dixon was reinstated on Friday by University administration after being placed on administrative leave on Monday. The...
Sat Oct 4, 2025

Lucas: Eric Church’s public service makes him ideal for UNC's 2026 Commencement
Eric Church has been all over the world. He’s played the biggest stages in music. He’s hosted the largest concert in North Carolina’s history. He’s...
Wed Oct 1, 2025